A sound regulatory pathway does not begin by choosing a form or uploading files. It begins by establishing the device identity, intended purpose, responsible parties, and current evidence baseline. This reduces rework and prevents a registration plan from being built on incomplete assumptions.

1. Establish the device baseline

Collect the trade name, legal manufacturer, models and accessories, intended purpose, target user, use environment, markets where the device is supplied, and current approvals or certificates. This information should be consistent across the label, instructions for use, and technical documentation.

2. Test the expected classification and pathway

Classification is not an isolated administrative field. It affects evidence depth, requirements, and the review pathway. The rationale should be documented against the intended purpose and device characteristics, then checked against the Saudi requirements applicable to the specific case.

3. Test evidence readiness, not file count

  • Consistent device and model descriptions across the dossier.
  • Traceability from risks and safety and performance requirements to verification and validation results.
  • Adequate clinical or performance evidence for the device type.
  • Labels, instructions, and claims aligned with available evidence.
  • Clear responsibilities for the manufacturer, local parties, and required updates.

4. Turn the assessment into an executable plan

The useful output is not a generic checklist. It is a gap register that records the available evidence, regulatory impact, priority, owner, required action, and closure criterion for each observation. Only then can a realistic submission and follow-up sequence be planned.

References: [1] [2]

Official sources

  1. SFDA — Requirements for Medical Devices Marketing Authorization (MDS-REQ 1)
  2. SFDA — MDS-REQ 1 (Arabic PDF)